Vivoryon Therapeutics N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
09 mrt 2016 - 08:02
Statutaire naam
Vivoryon Therapeutics N.V.
Titel
Probiodrug's pGlu-Abeta Approaches being presented at 14th AAT Symposium on Advances in Alzheimer Therapy
Bericht
Probiodrug's pGlu-Abeta Approaches being presented at 14th AAT Symposium on Advances in Alzheimer Therapy
The Symposium will be held from 9 to 12 March 2016 at the Athens Hilton in Athens, Greece
HALLE/SAALE, Germany, 09 March 2016 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease, announces today that Prof Dr Cynthia A. Lemere and Prof Dr Hans-Ulrich Demuth will be presenting at the 14th International Athens/Springfield Symposium on Advances in Alzheimer Therapy (AAT) in Athens, Greece.
Gerelateerde downloads
Datum laatste update: 15 juli 2025